O(6)-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas

Temozolomide (TMZ) is an alkylating agent currently used as first-line therapy for gliomas treatment due to its DNA-damaging effect. However, drug resistance occurs, preventing multi-cycle use of this chemotherapeutic agent. One of the major mechanisms of cancer drug resistance is enhanced activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, C-H, Liu, W-L, Cao, H, Wen, C, Chen, L, Jiang, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648381/
https://www.ncbi.nlm.nih.gov/pubmed/24157870
http://dx.doi.org/10.1038/cddis.2013.388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648381/
https://www.ncbi.nlm.nih.gov/pubmed/24157870
http://dx.doi.org/10.1038/cddis.2013.388

Ejemplares similares